289 related articles for article (PubMed ID: 15492280)
1. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.
Maudsley S; Davidson L; Pawson AJ; Chan R; López de Maturana R; Millar RP
Cancer Res; 2004 Oct; 64(20):7533-44. PubMed ID: 15492280
[TBL] [Abstract][Full Text] [Related]
2. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
Harrison GS; Wierman ME; Nett TM; Glode LM
Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
[TBL] [Abstract][Full Text] [Related]
5. Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor.
Naor Z
Front Neuroendocrinol; 2009 Jan; 30(1):10-29. PubMed ID: 18708085
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
Fister S; Günthert AR; Emons G; Gründker C
Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview.
So WK; Cheng JC; Poon SL; Leung PC
FEBS J; 2008 Nov; 275(22):5496-511. PubMed ID: 18959739
[TBL] [Abstract][Full Text] [Related]
8. A crucial role for Galphaq/11, but not Galphai/o or Galphas, in gonadotropin-releasing hormone receptor-mediated cell growth inhibition.
White CD; Coetsee M; Morgan K; Flanagan CA; Millar RP; Lu ZL
Mol Endocrinol; 2008 Nov; 22(11):2520-30. PubMed ID: 18801931
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone in apoptosis of prostate cancer cells.
Kraus S; Naor Z; Seger R
Cancer Lett; 2006 Mar; 234(2):109-23. PubMed ID: 16546667
[TBL] [Abstract][Full Text] [Related]
10. An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion.
Krsmanovic LZ; Mores N; Navarro CE; Arora KK; Catt KJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2969-74. PubMed ID: 12591945
[TBL] [Abstract][Full Text] [Related]
11. Induction of PER1 mRNA expression in immortalized gonadotropes by gonadotropin-releasing hormone (GnRH): involvement of protein kinase C and MAP kinase signaling.
Olcese J; Sikes HE; Resuehr D
Chronobiol Int; 2006; 23(1-2):143-50. PubMed ID: 16687288
[TBL] [Abstract][Full Text] [Related]
12. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth and proliferation of EcRG293 cell line expressing high-affinity gonadotropin-releasing hormone (GnRH) receptor under the control of an inducible promoter by GnRH agonist (D-Lys6)GnRH and antagonist (Antide).
Kakar SS
Cancer Res; 1998 Oct; 58(20):4558-60. PubMed ID: 9788600
[TBL] [Abstract][Full Text] [Related]
14. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
[TBL] [Abstract][Full Text] [Related]
15. Functional diversity of signaling pathways through G protein-coupled receptor heterodimerization with a species-specific orphan receptor subtype.
Sakai T; Aoyama M; Kusakabe T; Tsuda M; Satake H
Mol Biol Evol; 2010 May; 27(5):1097-106. PubMed ID: 20026483
[TBL] [Abstract][Full Text] [Related]
16. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.
Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM
J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616
[TBL] [Abstract][Full Text] [Related]
17. A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates.
Neill JD; Duck LW; Sellers JC; Musgrove LC
Biochem Biophys Res Commun; 2001 Apr; 282(4):1012-8. PubMed ID: 11352653
[TBL] [Abstract][Full Text] [Related]
18. D2 dopamine receptor activation of potassium channels is selectively decoupled by Galpha-specific GoLoco motif peptides.
Webb CK; McCudden CR; Willard FS; Kimple RJ; Siderovski DP; Oxford GS
J Neurochem; 2005 Mar; 92(6):1408-18. PubMed ID: 15748159
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
[TBL] [Abstract][Full Text] [Related]
20. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]